Xu Z - Search Results

1

An update on targeting Hippo-YAP signaling in liver cancer.

Liu AM, Xu Z, Luk JM. Liu AM, et al. Among authors: xu z. Expert Opin Ther Targets. 2012 Mar;16(3):243-7. doi: 10.1517/14728222.2012.662958. Epub 2012 Feb 16. Expert Opin Ther Targets. 2012. PMID: 22335485

2

Proteomic identification of a monoclonal antibody recognizing caveolin-1 in hepatocellular carcinoma with metastatic potential.

Hu MY, Lam CT, Liu KD, Xu Z, Fatima S, Su YC, Tsang F, Chen J, Pang JZ, Qin LX, Luk JM. Hu MY, et al. Among authors: xu z. Protein Pept Lett. 2009;16(5):479-85. doi: 10.2174/092986609788167743. Protein Pept Lett. 2009. PMID: 19442226

3

Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.

Xu Z, Zhu H, Luk JM, Wu D, Gu D, Gong W, Tan Y, Zhou J, Tang J, Zhang Z, Wang M, Chen J. Xu Z, et al. Cancer. 2012 Nov 15;118(22):5489-96. doi: 10.1002/cncr.27599. Epub 2012 Apr 19. Cancer. 2012. PMID: 22517484 Free article.

4

Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma.

Huo X, Zhang Q, Liu AM, Tang C, Gong Y, Bian J, Luk JM, Xu Z, Chen J. Huo X, et al. Among authors: xu z. Oncol Rep. 2013 Feb;29(2):840-6. doi: 10.3892/or.2012.2176. Epub 2012 Dec 10. Oncol Rep. 2013. PMID: 23232767

5

Circulating markers for prognosis of hepatocellular carcinoma.

Wong KF, Xu Z, Chen J, Lee NP, Luk JM. Wong KF, et al. Among authors: xu z. Expert Opin Med Diagn. 2013 Jul;7(4):319-29. doi: 10.1517/17530059.2013.795146. Epub 2013 May 6. Expert Opin Med Diagn. 2013. PMID: 23642136 Review.

6

miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.

Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM. Liu AM, et al. Among authors: xu z. PLoS One. 2014 Jan 23;9(1):e86872. doi: 10.1371/journal.pone.0086872. eCollection 2014. PLoS One. 2014. PMID: 24466275 Free PMC article.

7

SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.

Xu Z, Chen Y, Gu D, Lee NP, Sun S, Gong W, Tan Y, Luk JM, Chen J. Xu Z, et al. Am J Transl Res. 2015 Feb 15;7(2):401-10. eCollection 2015. Am J Transl Res. 2015. PMID: 25901207 Free PMC article.

8

Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.

Wong KF, Liu AM, Hong W, Xu Z, Luk JM. Wong KF, et al. Among authors: xu z. Oncotarget. 2016 Nov 22;7(47):77683-77695. doi: 10.18632/oncotarget.12760. Oncotarget. 2016. PMID: 27765911 Free PMC article.

9

Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma.

Xu Z, Cao C, Xia H, Shi S, Hong L, Wei X, Gu D, Bian J, Liu Z, Huang W, Zhang Y, He S, Lee NP, Chen J. Xu Z, et al. Front Med. 2016 Mar;10(1):52-60. doi: 10.1007/s11684-016-0433-3. Epub 2016 Jan 25. Front Med. 2016. PMID: 26809466

10

A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma.

Shen L, Wen J, Zhao T, Hu Z, Song C, Gu D, He M, Lee NP, Xu Z, Chen J. Shen L, et al. Among authors: xu z. Onco Targets Ther. 2016 Apr 4;9:1945-51. doi: 10.2147/OTT.S100699. eCollection 2016. Onco Targets Ther. 2016. PMID: 27110123 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,386 results

Search Page